Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
14.51
+0.12 (0.83%)
Feb 21, 2025, 4:00 PM EST - Market closed
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Eton Pharmaceuticals stock have an average target of 24, with a low estimate of 18 and a high estimate of 33. The average target predicts an increase of 65.40% from the current stock price of 14.51.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 23, 2025.
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $33 | Strong Buy | Maintains | $17 → $33 | +127.43% | Jan 23, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +44.73% | Jan 10, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +24.05% | Jan 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +17.16% | Jan 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 → $15 | Strong Buy | Reiterates | $11 → $15 | +3.38% | Nov 26, 2024 |
Financial Forecast
Revenue This Year
38.66M
from 31.64M
Increased by 22.19%
Revenue Next Year
81.53M
from 38.66M
Increased by 110.87%
EPS This Year
-0.13
from -0.04
EPS Next Year
0.53
from -0.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 40.0M | 107.8M | 199.2M | |||
| Avg | 38.7M | 81.5M | 134.1M | |||
| Low | 36.9M | 64.3M | 98.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 26.3% | 178.9% | 144.3% | |||
| Avg | 22.2% | 110.9% | 64.5% | |||
| Low | 16.8% | 66.3% | 20.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.11 | 0.85 | 2.11 | |||
| Avg | -0.13 | 0.53 | 1.30 | |||
| Low | -0.17 | 0.18 | 0.56 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 297.9% | |||
| Avg | - | - | 145.5% | |||
| Low | - | - | 5.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.